Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

EGFR kinase inhibitor 2

SKU: orb3132806

Description

EGFR kinase inhibitor 2 (compound A-7) is a potent EGFR inhibitor targeting the mutations EGFRL858R/T790M/C797S and EGFRDel19/T790M/C797S. This compound shows potential in addressing acquired resistance in the treatment of non-small cell lung cancer.

Research Area

Cardiovascular Research, Pharmacology & Drug Discovery; Cell Biology, Signal Transduction

Images & Validation

Key Properties

FormulaC39H40N6O5
TargetEGFR

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • BGB283 [orb1146515]

    >98%

    1446090-77-2

    478.43

    C25H17F3N4O3

    100 mg, 250 mg, 1 g
  • Sunvozertinib [orb3032913]

    >98%

    2370013-12-8

    584.084708452225

    C29H35CLFN7O3

    100 mg, 250 mg, 1 g
  • BLU-451 [orb2647563]

    >98%

    2769954-39-2

    497.44757771492

    C24H19F4N7O

    250 mg, 100 mg, 1 g
  • Afatinib Dimaleate [orb1307469]

    >99.99% (May vary between batches)

    850140-73-7

    718.08

    C32H33ClFN5O11

    100 mg, 5 mg, 10 mg, 25 mg, 50 mg, 500 mg, 1 ml x 10 mM (in DMSO)
  • AG1557 [orb1306688]

    99.23% (May vary between batches)

    189290-58-2

    407.21

    C16H14IN3O2

    10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information